The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells

  1. Mendez, S.
  2. Traslavina, R.
  3. Hinchman, M.
  4. Huang, L.
  5. Green, P.
  6. Cynamon, M.H.
  7. Welch, J.T.
Revue:
Antimicrobial Agents and Chemotherapy

ISSN: 0066-4804 1098-6596

Année de publication: 2009

Volumen: 53

Número: 12

Pages: 5114-5121

Type: Article

DOI: 10.1128/AAC.01146-09 GOOGLE SCHOLAR

Objectifs de Développement Durable